Evidence map›Paper›PMID 29392130›Full record

ArticleBioMed research international2017

Silvia Sancilio, Silvio Di Staso, Stefano Sebastiani, Lucia Centurione, Nick Di Girolamo, Marco Ciancaglini, Roberta Di Pietro

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Phytochemical Profile and Antioxidant and Antiproliferative Activity ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Silvia SancilioDepartment of Pharmacy, G. d'Annunzio University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.
Silvio Di StasoOphthalmic Clinic, Department of Life, Health and Environmental Sciences, L'Aquila University, Piazzale S. Tommasi 1, 67100 L'Aquila, Italy.
Stefano SebastianiSebastiani Pharmacy, Via Italia 70, 65010 Spoltore, Italy.
Lucia CenturioneDepartment of Medicine and Ageing Science, School of Medicine and Health Sciences, G. d'Annunzio University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.
Nick Di GirolamoInflammatory Diseases Research Unit, School of Medical Sciences, The University of New South Wales, Sydney, NSW 2052, Australia.ORCID 0000-0002-0020-5730
Marco CiancagliniOphthalmic Clinic, Department of Life, Health and Environmental Sciences, L'Aquila University, Piazzale S. Tommasi 1, 67100 L'Aquila, Italy.
Roberta Di PietroDepartment of Medicine and Ageing Science, School of Medicine and Health Sciences, G. d'Annunzio University of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy.ORCID 0000-0002-0709-6901
University of Chieti-Pescara · ITUniversity of L'Aquila · ITUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pterygium is a relatively common eye disease that can display an aggressive clinical behaviour. To evaluate the

Indexed as

ApoptosisBiomarkersCells, CulturedCurcumaGene Expression RegulationHumansKeratinocytesKeratinsPlant ExtractsPterygiumReceptor, Platelet-Derived Growth Factor alphaVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1BiomarkersCAM 5.2 antigenKeratinsPlant ExtractsReceptor, Platelet-Derived Growth Factor alphaVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1VEGFA protein, human

Identifiers

PMID29392130
PMCPMC5748112
OpenAlexW2775478521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.